Cargando…
A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer
Background: Luminal B-like human epidermal growth factor receptor 2 negative (Luminal B [HER2−]) is the most common molecular subtype of breast cancer (BC). Since the relationship between Luminal B (HER2−) BC and liver metastasis (LM) is poorly defined, this retrospective study aimed to develop an L...
Autores principales: | Yue, Yuhan, Liang, Junqing, Wu, Yuruo, Tong, Weibing, Li, Dan, Cao, Xuchen, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580102/ https://www.ncbi.nlm.nih.gov/pubmed/36254567 http://dx.doi.org/10.1177/15330338221132669 |
Ejemplares similares
-
Clinicopathologic subtypes and compromise of lymph nodes in patients with breast cancer
por: Jaime Jans, B, et al.
Publicado: (2014) -
Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
por: Li, Yilun, et al.
Publicado: (2021) -
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
por: Maisonneuve, Patrick, et al.
Publicado: (2014) -
Efficacy of chemotherapy for lymph node-positive luminal A subtype breast cancer patients: an updated meta-analysis
por: Li, Yilun, et al.
Publicado: (2020) -
Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
por: Hashmi, Atif Ali, et al.
Publicado: (2018)